Coronavirus genomes carry the signatures of their habitats
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Coronaviruses such as SARS-CoV-2 regularly infect host tissues that express antiviral proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host immune responses is important in the effort to control the spread of infection. Two AVPs that may shape viral genomes are the zinc finger antiviral protein (ZAP) and the apolipoprotein B mRNA editing enzyme-catalytic polypeptide-like 3 (APOBEC3). The former binds to CpG dinucleotides to facilitate the degradation of viral transcripts while the latter frequently deaminates C into U residues which could generate notable viral sequence variations. We tested the hypothesis that both APOBEC3 and ZAP impose selective pressures that shape the genome of an infecting coronavirus. Our investigation considered a comprehensive number of publicly available genomes for seven coronaviruses (SARS-CoV-2, SARS-CoV, and MERS infecting Homo sapiens , Bovine CoV infecting Bos taurus , MHV infecting Mus musculus , HEV infecting Sus scrofa , and CRCoV infecting Canis lupus familiaris ). We show that coronaviruses that regularly infect tissues with abundant AVPs have CpG-deficient and U-rich genomes; whereas those that do not infect tissues with abundant AVPs do not share these sequence hallmarks. Among the coronaviruses surveyed herein, CpG is most deficient in SARS-CoV-2 and a temporal analysis showed a marked increase in C to U mutations over four months of SARS-CoV-2 genome evolution. Furthermore, the preferred motifs in which these C to U mutations occur are the same as those subjected to APOBEC3 editing in HIV-1. These results suggest that both ZAP and APOBEC3 shape the SARS-CoV-2 genome: ZAP imposes a strong CpG avoidance, and APOBEC3 constantly edits C to U. Evolutionary pressures exerted by host immune systems onto viral genomes may motivate novel strategies for SARS-CoV-2 vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A BenjaminiHochberg false discovery rate correction [72] was then applied to the weighted p-values to account for multiple comparisons [73].”
MethodFagerberg, L., Hallström, B. M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035600 · Cited by 3,665
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · cited 1×
“SARS-CoV-2 infection triggers T cell response in infected patients [94], and the ability of CD4 T cells to recognize a virus would then allow APOBEC3 enzymes to be packaged into the virions and cause RNA-editing [20].”
BackgroundA comparative encyclopedia of DNA elements in the mouse genome
Yue, F., Cheng, Y., Breschi, A., Vierstra, J., Wu, W., Ryba, T., Sandstrom, R., Ma, Z., Davis, C., Pope, B. D., et al. (2014) · Nature · doi:10.1038/nature13992 · Cited by 1,781
SARS-CoV-2 productively infects human gut enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · Science · doi:10.1126/science.abc1669 · Cited by 1,573 · cited 1×
“For instance, SARS-CoV-2 regularly infects bronchiolar and type II alveolar epithelial cells in the lungs [1] and enterocytes in the small intestines [2].”
BackgroundLung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
Cunningham, F., Achuthan, P., Akanni, W., Allen, J., Amode, M. R., Armean, I. M., Bennett, R., Bhai, J., Billis, K., Boddu, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1113 · Cited by 925
CG dinucleotide suppression enables antiviral defence targeting non-self RNA
Takata, M. A., Gonçalves-Carneiro, D., Zang, T. M., Soll, S. J., York, A., Blanco-Melo, D., & Bieniasz, P. D. (2017) · Nature · doi:10.1038/nature24039 · Cited by 398 · cited 4×
“However, ZAP-mediated RNA degradation is cumulative [7].”
BackgroundResultInfluentialModerate mutation rate in the SARS coronavirus genome and its implications
Zhao, Z., Li, H., Wu, X., Zhong, Y., Zhang, K., Zhang, Y.-P., Boerwinkle, E., & Fu, Y.-X. (2004) · BMC Evolutionary Biology · doi:10.1186/1471-2148-4-21 · Cited by 286
Pervasive CpG suppression in animal mitochondrial genomes
Cardon, L. R., Burge, C., Clayton, D. A., & Karlin, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3799 · Cited by 238 · cited 1×
“Finally, the conventional index of CpG deficiency (ICpG) [76, 77] was calculated, using the formula below: ICpG 1⁄4 PCG PCPG ð3Þ”
MethodAtkinson, N. J., Witteveldt, J., Evans, D. J., & Simmonds, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku075 · Cited by 192 · cited 1×
“Many other pathogenic single-stranded RNA viruses, including coronaviruses, also exhibit strong CpG deficiency (Atkinson et al. 2014; Greenbaum et al. 2008; Greenbaum et al. 2009; Takata et al. 2017; Yap et al. 2003), but selection for CpG deficiency disappears in ZAP-deficient cells (Takata et al.…”
TISSUES 2.0: an integrative web resource on mammalian tissue expression
Palasca, O., Santos, A., Stolte, C., Gorodkin, J., & Jensen, L. J. (2018) · Database · doi:10.1093/database/bay003 · Cited by 182 · cited 3×
“…using the Bovine Genome Database (Shamimuzzaman et al. 2019), from averaged FPKM values in 33 pig tissues using TISSUE 2.0 integrated datasets (Palasca et al. 2018), from averaged FPKM values in 17 mice tissues using all 741 RNA-Seq datasets in mouse ENCODE consortium (Yue et al. 2014), from…”
MethodInfluentialTulloch, F., Atkinson, N. J., Evans, D. J., Ryan, M. D., & Simmonds, P. (2014) · eLife · doi:10.7554/elife.04531 · Cited by 178
Burns, C. C., Campagnoli, R., Shaw, J., Vincent, A., Jorba, J., & Kew, O. (2009) · Journal of Virology · doi:10.1128/jvi.00508-09 · Cited by 170
Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense
Xia, X. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa094 · Cited by 160 · cited 4×
“Thus, although SARS-CoV-2 has the lowest genomic CpG contents found in Betacoronaviruses (Xia 2020), only ORF1aband spike (S) mRNAs are likely targets by ZAP.”
BackgroundResultInfluentialSelf-citationNchioua, R., Kmiec, D., Müller, J. A., Conzelmann, C., Groß, R., Swanson, C. M., Neil, S. J. D., Stenger, S., Sauter, D., Münch, J., et al. (2020) · mBio · doi:10.1128/mbio.01930-20 · Cited by 146
Greenbaum, B. D., Rabadan, R., & Levine, A. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005969 · Cited by 76
Cited by
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
Xia, X. (2021) · Viruses · doi:10.3390/v13010109 · Cited by 319
“For this reason, viruses with different cell tropism may accumulate tissue-specific genomic signatures [33].”
BackgroundSelf-citationThe roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness
Kim, K., Calabrese, P., Wang, S., Qin, C., Rao, Y., Feng, P., & Chen, X. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-19067-x · Cited by 115
Sadykov, M., Mourier, T., Guan, Q., & Pain, A. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab011 · Cited by 15
Farookhi, H., & Xia, X. (2024) · Microorganisms · doi:10.3390/microorganisms12040768 · Cited by 7
Self-citation
Metadata
- Authors
- Wei, Y., Silke, J. R., Aris, P., & Xia, X.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-12-22
- Volume
- 15
- Issue
- 12
- Pages
- e0244025
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W3115292116
- Cited by
- 29
- References
- 18
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.